secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001641172-25-015653
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma moves principal executive office to Estero, Florida
--------------------------------------------------------------------

- Board changed principal executive office to 23150 Fashion Drive, Suite 232, Estero, FL 33928 effective June 17, 2025.
- Former address was 194 Candelaro Drive, #233, Humacao, Puerto Rico 00791.
- New office is the company's principal place of business and headquarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000164117225015653/0001641172-25-015653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000164117225015653/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer